Income Statement

v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Apr. 30, 2018
Apr. 30, 2017
Apr. 30, 2018
Apr. 30, 2017
Income Statement [Abstract]        
Net revenues $ 3 $ 16
Cost of sales 1 2
Gross profit 2 14
Operating costs and expenses        
Product research and development 5,621 12,223
Research and development - intellectual property acquired 104,693 104,693
General and administrative 5,938 5,686 16,836 10,911
Operating costs and expenses total 11,559 110,379 29,059 115,604
Other (expenses) income        
Interest income 18 3 43 7
Change in fair value of derivatives 440 3,814 (8)
Loss on extinguishment of warrant liability (520) (520)
Net loss from continuing operations (11,619) (110,376) (25,708) (115,605)
Gain (loss) from discontinued operations 16 (416)
Net loss (11,619) (110,360) (25,708) (116,021)
Deemed dividend - accretion of discount on Series F preferred stock (386) (1,290)
Deemed dividend - exchange of Series F preferred stock (7,057) (7,057)
Cumulative dividends on Series F preferred stock 98 (373)
Net loss attributable to common stockholders $ (19,160) $ (110,360) $ (34,428) $ (116,021)
Net loss per share, basic and diluted:        
Loss from continuing operations $ (0.89) $ (23.51) $ (2.63) $ (28.83)
Gain (loss) from discontinued operations 0.01 (0.10)
Deemed dividend - accretion of discount on preferred stock (0.03) (0.13)
Deemed dividend - exchange of Series F preferred stock (0.54) (0.72)
Cumulative dividends on Series F preferred stock (0.01) (0.04)
Net loss attributable to common stockholders $ (1.47) $ (23.50) $ (3.52) $ (28.93)
Weighted average shares outstanding, basic and diluted: 13,055,314 4,695,298 9,781,962 4,009,853

Source